Literature DB >> 19255723

Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells.

Eduardo J S Salustiano1, Chaquip D Netto, Renata F Fernandes, Alcides J M da Silva, Thiago S Bacelar, Carolina P Castro, Camilla D Buarque, Raquel C Maia, Vivian M Rumjanek, Paulo R R Costa.   

Abstract

The pentacyclic 1,4-naphthoquinones 1a-d were cytotoxic (IC(50) approximately 2-7 microM) to human leukemic cell lines K562 (oxidative stress-resistant), Lucena-1 (MDR phenotype) and Daudi. Fresh leukemic cells obtained from patients, some with the MDR phenotype, were also sensitive to these compounds. The pentacyclic 1,4-naphthoquinones 1a and 1c induced apoptotic cell death in cells from leukemic patients as determined by flow cytometry. Conversely, the cell lines were highly insensitive to lapachol (2) and alpha-lapachone (3). Mitomycin-C inhibited cell proliferation at concentrations as low as 0.5 microM. The low toxicity against lymphocytes activated by phytohemagglutinin shows that these compounds are selective for the cancer cells studied. Previous data suggest that these compounds (1a-d) can be bioactivated in situ by reduction followed by rearrangement leading to enones, which are powerful alkylating agents. In contrast, lapachol (2) and beta-lapachone (3), which cannot be bioactivated by reduction, showed little activity against the same cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255723     DOI: 10.1007/s10637-009-9231-y

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  29 in total

Review 1.  Mechanisms of in situ activation for DNA-targeting antitumor agents.

Authors:  Scott E Wolkenberg; Dale L Boger
Journal:  Chem Rev       Date:  2002-07       Impact factor: 60.622

2.  Isolation and structure identification of an active DNA strand-scission agent, (+)-3,4-di-hydroxy-8,9-methylenedioxypterocarpan.

Authors:  S K Chaudhuri; L Huang; F Fullas; D M Brown; M C Wani; M E Wall
Journal:  J Nat Prod       Date:  1995-12       Impact factor: 4.050

Review 3.  The role of hypoxia-activated prodrugs in cancer therapy.

Authors:  W A Denny
Journal:  Lancet Oncol       Date:  2000-09       Impact factor: 41.316

Review 4.  Naturally occurring quinones as potential bioreductive alkylating agents.

Authors:  H W Moore; R Czerniak
Journal:  Med Res Rev       Date:  1981       Impact factor: 12.944

5.  Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes.

Authors:  M D Esposti; I Hatzinisiriou; H McLennan; S Ralph
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

6.  Electrochemical study of oxygen interaction with lapachol and its radical anions.

Authors:  Marília O F Goulart; Piotr Falkowski; Tadeusz Ossowski; Adam Liwo
Journal:  Bioelectrochemistry       Date:  2003-04       Impact factor: 5.373

7.  Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation.

Authors:  Heon Joo Park; Ki-Jung Ahn; Seung-Do Ahn; Eunkyung Choi; Sang Wook Lee; Brent Williams; Eun Jung Kim; Robert Griffin; Erik A Bey; William G Bornmann; Jinming Gao; Heon Jin Park; David A Boothman; Chang W Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 8.013

8.  NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.

Authors:  J J Pink; S M Planchon; C Tagliarino; M E Varnes; D Siegel; D A Boothman
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.486

9.  Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.

Authors:  Cristian Salas; Ricardo A Tapia; Karina Ciudad; Verónica Armstrong; Myriam Orellana; Ulrike Kemmerling; Jorge Ferreira; Juan Diego Maya; Antonio Morello
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.461

10.  Redox cycling of beta-lapachone and related o-naphthoquinones in the presence of dihydrolipoamide and oxygen.

Authors:  M P Molina Portela; A O Stoppani
Journal:  Biochem Pharmacol       Date:  1996-02-09       Impact factor: 6.100

View more
  10 in total

1.  Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.

Authors:  Panupong Mahalapbutr; Ronnakorn Leechaisit; Anusit Thongnum; Duangjai Todsaporn; Veda Prachayasittikul; Thanyada Rungrotmongkol; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul; Ratchanok Pingaew
Journal:  ACS Omega       Date:  2022-05-18

2.  In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.

Authors:  Eduardo J Salustiano; Matheus L Dumas; Gabriel G Silva-Santos; Chaquip D Netto; Paulo R R Costa; Vivian M Rumjanek
Journal:  Invest New Drugs       Date:  2016-05-18       Impact factor: 3.850

3.  Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.

Authors:  Eduardo J Salustiano; Kelli M da Costa; Leonardo Freire-de-Lima; Lucia Mendonça-Previato; José O Previato
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

4.  Encapsulation of nor-β-lapachone into poly(d,l)-lactide-co-glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines.

Authors:  Marcília P Costa; Anderson C S Feitosa; Fátima C E Oliveira; Bruno C Cavalcanti; Gleiston G Dias; Ewerton W S Caetano; Francisco A M Sales; Valder N Freire; Stefano Di Fiore; Rainer Fischer; Luiz O Ladeira; Eufrânio N da Silva Júnior; Claudia Pessoa
Journal:  Medchemcomm       Date:  2017-09-07       Impact factor: 3.597

Review 5.  Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?

Authors:  Vivian M Rumjanek; Raphael S Vidal; Raquel C Maia
Journal:  Biosci Rep       Date:  2013-11-25       Impact factor: 3.840

6.  Cytotoxicity, hemolysis and in vivo acute toxicity of 2-hydroxy-3-anilino-1,4-naphthoquinone derivatives.

Authors:  Valeska Santana de Sena Pereira; Cláudio Bruno Silva de Oliveira; Fernando Fumagalli; Flávio da Silva Emery; Naisandra Bezerra da Silva; Valter F de Andrade-Neto
Journal:  Toxicol Rep       Date:  2016-09-16

7.  Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity.

Authors:  Qunying Chen; Lu Bai; Xuelin Zhou; Pingxiang Xu; Xiaorong Li; Huanli Xu; Yuanyuan Zheng; Yuming Zhao; Shousi Lu; Ming Xue
Journal:  RSC Adv       Date:  2020-08-14       Impact factor: 4.036

8.  A photochemical and theoretical study of the triplet reactivity of furano- and pyrano-1,4-naphthoquionones towards tyrosine and tryptophan derivatives.

Authors:  Rodolfo I Teixeira; Juliana S Goulart; Rodrigo J Corrêa; Simon J Garden; Sabrina B Ferreira; José Carlos Netto-Ferreira; Vitor F Ferreira; Paula Miro; M Luisa Marin; Miguel A Miranda; Nanci C de Lucas
Journal:  RSC Adv       Date:  2019-04-30       Impact factor: 4.036

9.  Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells.

Authors:  Thaís Oliveira; Douglas Lemos; Louise Jean; Jéssica M Kawashima; Vitória R de Azevedo; Eduardo J Salustiano; Vivian M Rumjanek; Robson Q Monteiro
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 10.  Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues.

Authors:  Danielly C Ferraz da Costa; Luciana Pereira Rangel; Mafalda Maria Duarte da Cunha Martins-Dinis; Giulia Diniz da Silva Ferretti; Vitor F Ferreira; Jerson L Silva
Journal:  Molecules       Date:  2020-02-18       Impact factor: 4.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.